Cargando…
Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis
BACKGROUND: To improve early infant HIV diagnosis (EID) programs, options include replacing laboratory-based tests with point-of-care (POC) assays or investing in strengthened systems for sample transport and result return. SETTING: We used the CEPAC-Pediatric model to examine clinical benefits and...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302325/ https://www.ncbi.nlm.nih.gov/pubmed/32520910 http://dx.doi.org/10.1097/QAI.0000000000002384 |
_version_ | 1783547822012891136 |
---|---|
author | McCann, Nicole C. Cohn, Jennifer Flanagan, Clare Sacks, Emma Mukherjee, Sushant Walensky, Rochelle P. Adetunji, Oluwarantimi Maeka, Kenneth K. Panella, Christopher Chadambuka, Addmore Mafaune, Haurovi Odhiambo, Collins Freedberg, Kenneth A. Ciaranello, Andrea L. |
author_facet | McCann, Nicole C. Cohn, Jennifer Flanagan, Clare Sacks, Emma Mukherjee, Sushant Walensky, Rochelle P. Adetunji, Oluwarantimi Maeka, Kenneth K. Panella, Christopher Chadambuka, Addmore Mafaune, Haurovi Odhiambo, Collins Freedberg, Kenneth A. Ciaranello, Andrea L. |
author_sort | McCann, Nicole C. |
collection | PubMed |
description | BACKGROUND: To improve early infant HIV diagnosis (EID) programs, options include replacing laboratory-based tests with point-of-care (POC) assays or investing in strengthened systems for sample transport and result return. SETTING: We used the CEPAC-Pediatric model to examine clinical benefits and costs of 3 EID strategies in Zimbabwe for infants 6 weeks of age. METHODS: We examined (1) laboratory-based EID (LAB), (2) strengthened laboratory-based EID (S-LAB), and (3) POC EID (POC). LAB/S-LAB and POC assays differed in sensitivity (LAB/S-LAB 100%, POC 96.9%) and specificity (LAB/S-LAB 99.6%, POC 99.9%). LAB/S-LAB/POC algorithms also differed in: probability of result return (79%/91%/98%), time until result return (61/53/1 days), probability of initiating antiretroviral therapy (ART) after positive result (52%/71%/86%), and total cost/test ($18.10/$30.47/$30.71). We projected life expectancy (LE) and average lifetime per-person cost for all HIV-exposed infants. We calculated incremental cost-effectiveness ratios (ICERs) from discounted (3%/year) LE and costs in $/year-of-life saved (YLS), defining cost effective as an ICER <$580/YLS (reflecting programs providing 2 vs. 1 ART regimens). In sensitivity analyses, we varied differences between S-LAB and POC in result return probability, result return time, ART initiation probability, and cost. RESULTS: For infants who acquired HIV, LAB/S-LAB/POC led to projected one-year survival of 67.3%/69.9%/75.6% and undiscounted LE of 21.74/22.71/24.49 years. For all HIV-exposed infants, undiscounted LE was 63.35/63.38/63.43 years, at discounted lifetime costs of $200/220/240 per infant. In cost-effectiveness analysis, S-LAB was an inefficient use of resources; the ICER of POC vs. LAB was $830/YLS. CONCLUSIONS: Current EID programs will attain greater benefit from investing in POC EID rather than strengthening laboratory-based systems. |
format | Online Article Text |
id | pubmed-7302325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | JAIDS Journal of Acquired Immune Deficiency Syndromes |
record_format | MEDLINE/PubMed |
spelling | pubmed-73023252020-06-29 Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis McCann, Nicole C. Cohn, Jennifer Flanagan, Clare Sacks, Emma Mukherjee, Sushant Walensky, Rochelle P. Adetunji, Oluwarantimi Maeka, Kenneth K. Panella, Christopher Chadambuka, Addmore Mafaune, Haurovi Odhiambo, Collins Freedberg, Kenneth A. Ciaranello, Andrea L. J Acquir Immune Defic Syndr Supplement Article BACKGROUND: To improve early infant HIV diagnosis (EID) programs, options include replacing laboratory-based tests with point-of-care (POC) assays or investing in strengthened systems for sample transport and result return. SETTING: We used the CEPAC-Pediatric model to examine clinical benefits and costs of 3 EID strategies in Zimbabwe for infants 6 weeks of age. METHODS: We examined (1) laboratory-based EID (LAB), (2) strengthened laboratory-based EID (S-LAB), and (3) POC EID (POC). LAB/S-LAB and POC assays differed in sensitivity (LAB/S-LAB 100%, POC 96.9%) and specificity (LAB/S-LAB 99.6%, POC 99.9%). LAB/S-LAB/POC algorithms also differed in: probability of result return (79%/91%/98%), time until result return (61/53/1 days), probability of initiating antiretroviral therapy (ART) after positive result (52%/71%/86%), and total cost/test ($18.10/$30.47/$30.71). We projected life expectancy (LE) and average lifetime per-person cost for all HIV-exposed infants. We calculated incremental cost-effectiveness ratios (ICERs) from discounted (3%/year) LE and costs in $/year-of-life saved (YLS), defining cost effective as an ICER <$580/YLS (reflecting programs providing 2 vs. 1 ART regimens). In sensitivity analyses, we varied differences between S-LAB and POC in result return probability, result return time, ART initiation probability, and cost. RESULTS: For infants who acquired HIV, LAB/S-LAB/POC led to projected one-year survival of 67.3%/69.9%/75.6% and undiscounted LE of 21.74/22.71/24.49 years. For all HIV-exposed infants, undiscounted LE was 63.35/63.38/63.43 years, at discounted lifetime costs of $200/220/240 per infant. In cost-effectiveness analysis, S-LAB was an inefficient use of resources; the ICER of POC vs. LAB was $830/YLS. CONCLUSIONS: Current EID programs will attain greater benefit from investing in POC EID rather than strengthening laboratory-based systems. JAIDS Journal of Acquired Immune Deficiency Syndromes 2020-07-01 2020-06-15 /pmc/articles/PMC7302325/ /pubmed/32520910 http://dx.doi.org/10.1097/QAI.0000000000002384 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Supplement Article McCann, Nicole C. Cohn, Jennifer Flanagan, Clare Sacks, Emma Mukherjee, Sushant Walensky, Rochelle P. Adetunji, Oluwarantimi Maeka, Kenneth K. Panella, Christopher Chadambuka, Addmore Mafaune, Haurovi Odhiambo, Collins Freedberg, Kenneth A. Ciaranello, Andrea L. Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis |
title | Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis |
title_full | Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis |
title_fullStr | Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis |
title_full_unstemmed | Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis |
title_short | Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis |
title_sort | strengthening existing laboratory-based systems vs. investing in point-of-care assays for early infant diagnosis of hiv: a model-based cost-effectiveness analysis |
topic | Supplement Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302325/ https://www.ncbi.nlm.nih.gov/pubmed/32520910 http://dx.doi.org/10.1097/QAI.0000000000002384 |
work_keys_str_mv | AT mccannnicolec strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT cohnjennifer strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT flanaganclare strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT sacksemma strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT mukherjeesushant strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT walenskyrochellep strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT adetunjioluwarantimi strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT maekakennethk strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT panellachristopher strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT chadambukaaddmore strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT mafaunehaurovi strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT odhiambocollins strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT freedbergkennetha strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis AT ciaranelloandreal strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis |